Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00360594 · ClinicalTrials.gov registry record · Phase 2

Acamprosate Initiated During Alcohol Detoxification

A Phase 2 study of Alcohol Use Disorder, sponsored by Forest Laboratories.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT00360594 is a Phase 2 study of Alcohol Use Disorder that has completed, run by Forest Laboratories. The registered enrollment target is 40 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00360594, a Phase 2 study of Alcohol Use Disorder, has completed, sponsored by Forest Laboratories.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Acamprosate is approved by the Food and Drug Administration (FDA) for the treatment of alcoholism. The purpose of this study is to see if initiating acamprosate early in alcohol detoxification instead of waiting until detoxification has been completed effects the course of detoxification, adverse events during detoxification, drop out rate during the rehabilitative treatment phase, or overall efficacy of acamprosate for those with alcohol dependence who plan to receive at least two months of rehabilitative pharmacotherapy with acamprosate.

Conditions Studied

Alcohol Use Disorder

Interventions

  • DRUG Placebo
  • DRUG Acamprosate

Study Locations (1)

Pennsylvania

  • Treatment Research Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-10
Est. Completion 2007-11
Phase Phase 2

Sponsor

Forest Laboratories

145 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00360594

The ClinicalTrials.gov registry entry for NCT00360594 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (88% lower). The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00360594 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00360594 about?

NCT00360594 is a clinical study titled "Acamprosate Initiated During Alcohol Detoxification". Acamprosate is approved by the Food and Drug Administration (FDA) for the treatment of alcoholism. The purpose of this study is to see if initiating acamprosate early in alcohol detoxification instead of waiting until detoxification has been completed effects the course of detoxification, adverse ev...

What is the current status of trial NCT00360594?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2006-10. Estimated completion is 2007-11.

What conditions does trial NCT00360594 study?

This clinical trial studies the following conditions: Alcohol Use Disorder.

What interventions are being tested in trial NCT00360594?

The interventions under investigation include: Placebo (DRUG), Acamprosate (DRUG).

Who is sponsoring clinical trial NCT00360594?

This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00360594 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alcohol Use Disorder

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.